Results 211 to 220 of about 63,859 (253)

Weizmannia coagulans BC01 supplementation improved functional constipation by regulating gut microbiota: A randomized, placebo-controlled, clinical study. [PDF]

Medicine (Baltimore)
Xu Y, Zhang Y, Yue F, Yu X, Chen Y, Ma X.   +5 more
europepmc   +1 more source

[Seoul Consensus on Clinical Practice Guidelines for Functional Constipation]. [PDF]

Korean J Gastroenterol
Song KH, Cho YS, Shin JE, Jung HK, Park SY, Kang SJ, Kim JW, Lee YJ, Lim HC, Park HS, Kim SJ, Cha RR, Bang KB, Bang CS, Yim SK, Ryoo SB, Kye BH, Ji WB, Choi M, Sung IK, Choi SC.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

FUNCTIONAL CONSTIPATION IN CHILDREN

Journal of Urology, 2004
Constipation in children increases the likelihood of urinary incontinence, bladder overactivity, dyscoordinated voiding, a large capacity, poorly emptying bladder, recurrent urinary tract infection and deterioration of vesicoureteral reflux. We present a consensus related to the assessment, diagnosis and treatment of children with bowel dysfunction ...
J W, Chase, Y, Homsy, C, Siggaard, F, Sit, W F, Bower   +4 more
openaire   +2 more sources

Functional Constipation: A Case Report

Journal of Pediatric Health Care, 2021
Constipation is one of the most common chronic disorders in childhood. Functional constipation (FC) is the most common form of constipation and can be defined as difficult or infrequent passage of stool. Current practice guidelines for FC are well defined; however, primary provider perception and treatment often differ from clinical practice guidelines.
Andrea, Casias, Laurie, Newton
openaire   +2 more sources

Linaclotide (Linzess) for Functional Constipation

The Medical Letter on Drugs and Therapeutics, 2023
The guanylate cyclase-C receptor agonist linaclotide (Linzess – Abbvie/Ironwood) was first approved by the FDA in 2012 for treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.
openaire   +2 more sources

Age of Onset of Functional Constipation

Journal of Pediatric Gastroenterology and Nutrition, 2016
ABSTRACTIn a review of 538 children with functional constipation, we analyzed ages of presentation and onset, symptom duration, and behavioral/developmental problems. We divided the subjects into quartiles (Q1–Q4) based on age of onset. Median onset age was 2.3 years. The oldest group had the shortest symptom duration before referral at 1.8 ± 1.8 years
Stanton, Malowitz, Mary, Green, Aryn, Karpinski, Allan, Rosenberg, Paul E, Hyman   +4 more
openaire   +2 more sources

Management of functional constipation in childhood

British Journal of Community Nursing, 2003
Functional constipation is a common childhood condition. In the majority of cases the constipation develops as a result of a complex weave of factors including specific triggers, e.g. reduced fluid intake following a viral infection or periods of restricted access to the toilet.
openaire   +2 more sources

Oral Prucalopride in Children With Functional Constipation

Journal of Pediatric Gastroenterology and Nutrition, 2013
ABSTRACTBackground and Objectives:Prucalopride is a selective, high‐affinity 5‐HT4 receptor agonist with gastrointestinal prokinetic activities. The aim of this study was to evaluate the pharmacokinetics, efficacy, safety, and tolerability of prucalopride oral solution in children, ages 4 years or older to 12 years or younger, with functional ...
Winter, Harland S., Di Lorenzo, Carlo, Benninga, Marc A., Gilger, Mark A., Kearns, Gregory L., Hyman, Paul E., Vandeplassche, Lieve, Ausma, Jannie, Hoppenbrouwers, Mieke   +8 more
openaire   +2 more sources

Functional Constipation and the Gut Microbiome in Children: Preclinical and Clinical Evidence

Frontiers in Pediatrics, 2021
David Avelar Rodríguez, Jelena Popov, Elyanne M Ratcliffe   +2 more
exaly